Patent application number | Description | Published |
20090069373 | Quinoline Acids - This invention relates generally to quinoline-based modulators of Liver X receptors (LXRs) and related methods. | 03-12-2009 |
20090111802 | CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS - This invention provides compounds of Formula (I): | 04-30-2009 |
20090281096 | CYCLOTHIOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS - Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: | 11-12-2009 |
20110039839 | Cyanopyrroles - This invention provides a progesterone receptor antagonist of formula 1 having the structure | 02-17-2011 |
20130072480 | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators - Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: | 03-21-2013 |
20130261112 | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators - Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have the structure: | 10-03-2013 |
Patent application number | Description | Published |
20100120778 | QUINOXALINE-BASED LXR MODULATORS - Disclosed are quinoxaline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 05-13-2010 |
20100184786 | Polar Quinazolines - Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 07-22-2010 |
20100273816 | Quinazoline Compounds - Disclosed are quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 10-28-2010 |
20110034526 | Benzimidazole Compounds - This invention relates generally to benzimidazole-based modulators of Liver X receptors (LXRs) having formula (I) and related methods: | 02-10-2011 |
20110112135 | Imidazo [1,2-A] Pyridine Compounds - This invention relates generally to imidazo[1,2-a]pyridine-based modulators of Liver X receptors (LXRs) having formula (I) and related methods: | 05-12-2011 |
20150045401 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE - Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain cancer, and prostate cancer through the release of riluzole. Prodrugs of riluzole have enhanced stability to hepatic metabolism and are delivered into systemic circulation by oral administration, and then cleaved to release riluzole in the plasma via either an enzymatic or general biophysical release process. | 02-12-2015 |